Skip to content
★ Sign in to follow
AM

ABG Management Ltd

Related company / holding
Sorrento Therapeutics, Inc.
Total declarations
20
Company
1
▲ Purchases (3 ops.)
€5.7M
▼ Sales (14 ops.)
€7.3M

Latest filing published 14 Sept 2018 for Sorrento Therapeutics, Inc., €826k.

Filing timeline

BuySale
ABG Management Ltd

Insider track record

Disclosed buys
3
Disclosed sells
14
Signal history

Closed purchases

Market purchases
3

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

ABG Management Ltd: trading record in brief

ABG Management Ltd discloses dealings in Sorrento Therapeutics, Inc. to SEC (Form 4). In total, 20 filings cover trades dated from 5 January 2017 to 13 September 2018.

Market trades split into 3 purchases (€5.7M) and 14 sales (€7.3M). On balance, insiders were net sellers of €1.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2018, the count stands at no purchases and 14 sales.

A typical purchase (the median) is worth €1.9M.

The latest filing, published on 14 September 2018, reports an open-market sale of €826k in Sorrento Therapeutics, Inc. The most recent open-market purchase was published on 21 April 2017, 3,489 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to ABG Management Ltd

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations